JP2009544660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544660A5 JP2009544660A5 JP2009521246A JP2009521246A JP2009544660A5 JP 2009544660 A5 JP2009544660 A5 JP 2009544660A5 JP 2009521246 A JP2009521246 A JP 2009521246A JP 2009521246 A JP2009521246 A JP 2009521246A JP 2009544660 A5 JP2009544660 A5 JP 2009544660A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- carbon atoms
- equation
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 235000001014 amino acid Nutrition 0.000 claims 12
- 125000004432 carbon atoms Chemical group C* 0.000 claims 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 235000018102 proteins Nutrition 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 102000004357 Transferases Human genes 0.000 claims 8
- 108090000992 Transferases Proteins 0.000 claims 8
- -1 polyethyleneoxy group Polymers 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 125000002947 alkylene group Chemical group 0.000 claims 5
- 102000037240 fusion proteins Human genes 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 229940104302 Cytosine Drugs 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- 150000001408 amides Chemical group 0.000 claims 2
- 239000011616 biotin Substances 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- KRWMERLEINMZFT-UHFFFAOYSA-N O(6)-benzylguanine; Chemical compound C=12NC=NC2=NC(N)=NC=1OCC1=CC=CC=C1 KRWMERLEINMZFT-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 1
- VFJWZMBJSURNDU-UHFFFAOYSA-N CCN(CC)c1ccc(C=C(C(NCc2ccc(COc3nc(N)ccn3)cc2)=O)C(O2)=O)c2c1 Chemical compound CCN(CC)c1ccc(C=C(C(NCc2ccc(COc3nc(N)ccn3)cc2)=O)C(O2)=O)c2c1 VFJWZMBJSURNDU-UHFFFAOYSA-N 0.000 description 1
- CWIONTDGJVSLDU-PAGQWHICSA-N Nc1ccnc(OCc2ccc(CNC(CCCCCNC(CCCC[C@@H]([C@H]3N4)SCC3NC4=O)=O)=O)cc2)n1 Chemical compound Nc1ccnc(OCc2ccc(CNC(CCCCCNC(CCCC[C@@H]([C@H]3N4)SCC3NC4=O)=O)=O)cc2)n1 CWIONTDGJVSLDU-PAGQWHICSA-N 0.000 description 1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06117779A EP1882688A1 (en) | 2006-07-25 | 2006-07-25 | Labelling of fusion proteins with synthetic probes |
PCT/EP2007/057597 WO2008012296A1 (en) | 2006-07-25 | 2007-07-24 | Labelling of fusion proteins with synthetic probes |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009544660A JP2009544660A (ja) | 2009-12-17 |
JP2009544660A5 true JP2009544660A5 (US07794700-20100914-C00152.png) | 2010-06-24 |
Family
ID=36954295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009521246A Pending JP2009544660A (ja) | 2006-07-25 | 2007-07-24 | 合成プローブによる融合タンパク質の標識化 |
Country Status (5)
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005068616A2 (en) | 2004-01-16 | 2005-07-28 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Immunokinases |
AU2006264300B2 (en) | 2005-07-06 | 2012-03-08 | Vascular Pathways Inc. | Intravenous catheter insertion device and method of use |
EP1800695A1 (en) | 2005-12-21 | 2007-06-27 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Immuno-RNA-constructs |
ATE548972T1 (de) | 2007-05-07 | 2012-03-15 | Vascular Pathways Inc | Intravenöse kathetereinführungs- und blutprobenvorrichtung |
EP2171456A2 (en) * | 2007-07-25 | 2010-04-07 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Self coupling recombinant antibody fusion proteins |
WO2010031767A2 (en) * | 2008-09-16 | 2010-03-25 | Technische Universität München | Fluorescent-labelled atpases |
FR2936245B1 (fr) | 2008-09-23 | 2012-07-06 | Cis Bio Int | Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants. |
US9872971B2 (en) | 2010-05-14 | 2018-01-23 | C. R. Bard, Inc. | Guidewire extension system for a catheter placement device |
US8932258B2 (en) | 2010-05-14 | 2015-01-13 | C. R. Bard, Inc. | Catheter placement device and method |
US9950139B2 (en) | 2010-05-14 | 2018-04-24 | C. R. Bard, Inc. | Catheter placement device including guidewire and catheter control elements |
US11925779B2 (en) | 2010-05-14 | 2024-03-12 | C. R. Bard, Inc. | Catheter insertion device including top-mounted advancement components |
US10384039B2 (en) | 2010-05-14 | 2019-08-20 | C. R. Bard, Inc. | Catheter insertion device including top-mounted advancement components |
US8690833B2 (en) | 2011-01-31 | 2014-04-08 | Vascular Pathways, Inc. | Intravenous catheter and insertion device with reduced blood spatter |
WO2012154277A1 (en) | 2011-02-25 | 2012-11-15 | C.R. Bard, Inc. | Medical component insertion device including a retractable needle |
USD903101S1 (en) | 2011-05-13 | 2020-11-24 | C. R. Bard, Inc. | Catheter |
JP6522339B2 (ja) | 2011-11-21 | 2019-05-29 | プロメガ コーポレイションPromega Corporation | カルボキシxローダミン類似体 |
NO2788478T3 (US07794700-20100914-C00152.png) | 2011-12-09 | 2018-01-20 | ||
US9267117B2 (en) | 2012-03-15 | 2016-02-23 | New England Biolabs, Inc. | Mapping cytosine modifications |
CN104203286B (zh) * | 2012-03-21 | 2017-12-29 | 弗劳恩霍夫应用研究促进协会 | 用于光动力疗法的新型光免疫偶联物 |
CN108607150B (zh) | 2013-01-30 | 2021-01-12 | 血管通路股份有限公司 | 用于静脉穿刺和导管放置的系统和方法 |
US9782568B2 (en) | 2013-02-05 | 2017-10-10 | Vascular Pathways, Inc. | Systems and methods for needle and catheter advancement |
EP2972229B1 (en) | 2013-03-15 | 2017-12-27 | Promega Corporation | New silicon and germanium dyes for use in genetic identity |
US9708658B2 (en) | 2013-03-19 | 2017-07-18 | New England Biolabs, Inc. | Enrichment of target sequences |
US10080787B2 (en) | 2014-07-02 | 2018-09-25 | New England Biolabs, Inc. | Universal N-glycan binding reagent |
WO2016037127A1 (en) | 2014-09-05 | 2016-03-10 | C.R. Bard, Inc. | Catheter insertion device including retractable needle |
JP2017537657A (ja) | 2014-12-11 | 2017-12-21 | ニユー・イングランド・バイオレイブス・インコーポレイテツド | 標的配列の濃縮 |
USD903100S1 (en) | 2015-05-01 | 2020-11-24 | C. R. Bard, Inc. | Catheter placement device |
EP4029446A1 (en) | 2015-05-15 | 2022-07-20 | C.R. Bard, Inc. | Needle assembly including a blood flash indicator |
CN113444094B (zh) | 2016-07-20 | 2023-12-22 | 纳莹(上海)生物科技有限公司 | 一种荧光探针及其制备方法和用途 |
CN109715093B (zh) | 2016-09-12 | 2020-11-06 | C·R·巴德股份有限公司 | 导管插入装置的血液控制 |
JP6953541B2 (ja) | 2017-03-01 | 2021-10-27 | シー・アール・バード・インコーポレーテッドC R Bard Incorporated | カテーテル挿入装置 |
CN109574880B (zh) | 2017-09-29 | 2022-06-17 | 纳莹(上海)生物科技有限公司 | 一种荧光探针及其制备方法和用途 |
WO2019173641A1 (en) | 2018-03-07 | 2019-09-12 | Bard Access Systems, Inc. | Guidewire advancement and blood flashback systems for a medical device insertion system |
CN110498799B (zh) | 2018-05-18 | 2022-07-05 | 纳莹(上海)生物科技有限公司 | 一种荧光探针及其制备方法和用途 |
USD921884S1 (en) | 2018-07-27 | 2021-06-08 | Bard Access Systems, Inc. | Catheter insertion device |
CN111748089B (zh) * | 2019-03-28 | 2023-07-18 | 成都先导药物开发股份有限公司 | 一种生物素标记化合物以及确定化合物结合靶标蛋白的方法 |
US11390915B2 (en) | 2019-04-26 | 2022-07-19 | New England Biolabs, Inc. | Polynucleotide adapter design for reduced bias |
EP4010057A4 (en) | 2019-08-19 | 2023-10-18 | Becton, Dickinson and Company | CENTERLINE CATHETER PLACEMENT DEVICE |
WO2021183921A1 (en) | 2020-03-12 | 2021-09-16 | New England Biolabs, Inc. | A rapid diagnostic test for lamp |
US11740240B2 (en) * | 2020-07-20 | 2023-08-29 | Bio-Rad Laboratories, Inc. | Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor |
WO2022040443A2 (en) | 2020-08-21 | 2022-02-24 | New England Biolabs, Inc. | A rapid diagnostic test for lamp |
WO2023197015A1 (en) | 2022-04-08 | 2023-10-12 | New England Biolabs, Inc. | Compositions and analysis of dephosphorylated oligoribonucleotides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19600934A1 (de) * | 1996-01-12 | 1997-07-17 | Basf Ag | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
DE60041584D1 (de) * | 1999-07-28 | 2009-04-02 | Aventis Pharma Inc | Substituierte oxoazaheterozyclische verbindungen |
EP1546371A1 (en) * | 2002-10-03 | 2005-06-29 | Ecole Polytechnique Federale De Lausanne (Epfl) | Substrates for o6-alkylguanine-dna alkyltransferase |
WO2005085470A1 (en) * | 2004-03-02 | 2005-09-15 | Epfl Ecole Polytechnique Federale De Lausanne | Specific substrates for o6- alkylguanine-dna alkyltransferase |
US8178314B2 (en) * | 2005-04-27 | 2012-05-15 | Covalys Biosciences Ag | Pyrimidines reacting with O6-alkylguanine-DNA alkyltransferase fusion protein and method for detecting protein |
-
2006
- 2006-07-25 EP EP06117779A patent/EP1882688A1/en not_active Withdrawn
-
2007
- 2007-07-24 WO PCT/EP2007/057597 patent/WO2008012296A1/en active Application Filing
- 2007-07-24 CN CNA2007800339023A patent/CN101516857A/zh active Pending
- 2007-07-24 JP JP2009521246A patent/JP2009544660A/ja active Pending
- 2007-07-24 US US12/309,554 patent/US8227602B2/en active Active
- 2007-07-24 EP EP07787840A patent/EP2049499B1/en active Active
-
2012
- 2012-05-31 US US13/484,954 patent/US8623627B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009544660A5 (US07794700-20100914-C00152.png) | ||
US11808768B2 (en) | 1,1 ′-[[(substituted alkyl)imino]bis (alkylene)]bis- ferrocenes and their use in I electrochemical assays by labelling substrates of interest | |
JP2019514426A5 (US07794700-20100914-C00152.png) | ||
Pirrung et al. | High-Throughput Catch-and-Release Synthesis of Oxazoline Hydroxamates. Structure− Activity Relationships in Novel Inhibitors of Escherichia c oli LpxC: In Vitro Enzyme Inhibition and Antibacterial Properties | |
BRPI0516264A (pt) | molécula de ácido nucleico, seqüência de nucleotìdeos, cassete de expressão, vetor de expressão, célula, métodos para expressar um anticorpo recombinante ou fragmento do mesmo, para melhorar a expressão de um anticorpo recombinante ou fragmento do mesmo, para produzir um anticorpo recombinante ou fragmento do mesmo e uma preparação de anticorpos e para detectar um produto irt em uma amostra, anticorpo e composição farmacêutica | |
SG179448A1 (en) | Oxidation resistant indicator molecules | |
JP2015521616A5 (US07794700-20100914-C00152.png) | ||
Pitié et al. | Targeting the DNA Cleavage Activity of Copper Phenanthroline and Clip-Phen to A⊙ T Tracts via Linkage to a Poly-N-methylpyrrole | |
JP2010521485A5 (US07794700-20100914-C00152.png) | ||
JP2013078329A5 (US07794700-20100914-C00152.png) | ||
JP2016521250A5 (US07794700-20100914-C00152.png) | ||
MA29416B1 (fr) | Inhibiteurs d'age | |
JP2015511601A (ja) | 広域抗生物質アリロマイシン類縁体 | |
Shiyama et al. | Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins | |
JP2004525888A (ja) | オリゴまたはポリアルキレングリコール結合トロンビン阻害剤 | |
Milner et al. | Probing linker design in citric acid–ciprofloxacin conjugates | |
Caprioara et al. | DNA‐based phosphane ligands | |
Bakka et al. | Methyl propiolate and 3-butynone: Starting points for synthesis of amphiphilic 1, 2, 3-triazole peptidomimetics for antimicrobial evaluation | |
JP2011506296A5 (US07794700-20100914-C00152.png) | ||
Adler et al. | Enaminone‐based mimics of extended and hydrophilic α‐helices | |
JP2016505514A5 (US07794700-20100914-C00152.png) | ||
Stadlbauer et al. | Utilizing reversible copper (II) peptide coordination in a sequence‐selective luminescent receptor | |
JP2010030999A (ja) | テロメラーゼ阻害剤 | |
JP2011519884A5 (US07794700-20100914-C00152.png) | ||
EP3878472A1 (en) | Proteolysis targeting chimera (protac) for degradation of aurora a-kinase |